1. Kampen, K R, Scherpen, F J G, Garcia-Manero, G, Kornblau, S M, De Bont, E S J M. 2015. EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System. In Molecular cancer research : MCR, 13, 982-92. doi:10.1158/1541-7786.MCR-14-0660-T. https://pubmed.ncbi.nlm.nih.gov/25944917/
2. Yu, Shao-Nan, Liu, Gui-Feng, Li, Long-Yun, Liu, Lin, Li, Xue-Feng. 2018. Analgesic effects of microRNA-129-5p against bone cancer pain through the EphB1/EphrinB2 signaling pathway in mice. In Journal of cellular biochemistry, 120, 2876-2885. doi:10.1002/jcb.26605. https://pubmed.ncbi.nlm.nih.gov/29236320/
3. Wang, Lujuan, Peng, Qiu, Xie, Yaohuan, Tang, Jingqun, Xiang, Juanjuan. 2022. Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy. In Cell death & disease, 13, 980. doi:10.1038/s41419-022-05385-5. https://pubmed.ncbi.nlm.nih.gov/36402751/
4. Kundu, Snehangshu, Nunes, Luís, Adler, Jeremy, Stoimenov, Ivaylo, Sjöblom, Tobias. 2023. Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells. In Cell communication and signaling : CCS, 21, 354. doi:10.1186/s12964-023-01378-9. https://pubmed.ncbi.nlm.nih.gov/38102712/
5. Chen, Qin, Deng, Rong, Zhao, Xian, Huang, Jian, Yu, Jianxiu. 2018. Sumoylation of EphB1 Suppresses Neuroblastoma Tumorigenesis via Inhibiting PKCγ Activation. In Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 45, 2283-2292. doi:10.1159/000488174. https://pubmed.ncbi.nlm.nih.gov/29550816/
6. Wang, Haiyan, Wen, Juanjuan, Wang, Hai, Lu, Guangming, Wang, Jiandong. 2013. Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival. In International journal of clinical and experimental pathology, 7, 313-21. doi:. https://pubmed.ncbi.nlm.nih.gov/24427352/
智鼠故事 
